Zobrazeno 1 - 10
of 275
pro vyhledávání: '"Robin Thompson"'
Publikováno v:
Bio-Protocol, Vol 12, Iss 4 (2022)
Transfer RNAs (tRNAs) are highly abundant species and, along their biosynthetic and functional path, they establish interactions with a plethora of proteins. The high number of nucleobase modifications in tRNAs renders conventional RNA quantification
Externí odkaz:
https://doaj.org/article/292278872190478ca9ff2315da2a04dd
Autor:
Filipa Landeiro, Jasmine Morton, Anders Gustavsson, Michele Potashman, Pascal Lecomte, Mark Belger, Robin Thompson, Emilse Roncancio‐Diaz, Gurleen Jhuti, Christopher Butler, Linus Jönsson, Ron Handels, Alastair M. Gray, the ROADMAP study
Publikováno v:
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 8, Iss 1, Pp n/a-n/a (2022)
Abstract The successful development of an economic model for the evaluation of future Alzheimer's disease (AD) interventions is critical to accurately inform policy makers and payers. As our understanding of AD expands, this becomes an increasingly c
Externí odkaz:
https://doaj.org/article/8b096dbb28a34191a377db2b6db52ed4
Publikováno v:
Journal of Substance Use. :1-6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::baf60a8771e035790ea1a19503c1159d
https://doi.org/10.1080/14659891.2022.2144505
https://doi.org/10.1080/14659891.2022.2144505
Autor:
Marieke J. H. J. Dekker, Jacoline C. Bouvy, Diana O'Rourke, Robin Thompson, Amr Makady, Pall Jonsson, Christine C. Gispen-de Wied
Publikováno v:
Frontiers in Medicine, Vol 6 (2019)
Aims: To facilitate regulatory learning, we evaluated similarities and differences in evidence requirements between regulatory and health technology assessment (HTA) bodies of Alzheimer's disease (AD) approved products.Methods: The European marketing
Externí odkaz:
https://doaj.org/article/ddb542f1dac448c5b5ebf4e76cca4fb4
Publikováno v:
G3: Genes, Genomes, Genetics, Vol 6, Iss 5, Pp 1313-1326 (2016)
Genomic selection in crop breeding introduces modeling challenges not found in animal studies. These include the need to accommodate replicate plants for each line, consider spatial variation in field trials, address line by environment interactions,
Externí odkaz:
https://doaj.org/article/9f6edfe0bc40415eb09b5b028a8db6e2
Publikováno v:
Journal of Addictive Diseases. 40:538-541
Recovery housing provides substance-free living environments that use peer-support to empower individuals in recovery from substance use disorder. This study estimated the total revenue of the recovery housing industry from recovery houses, nationwid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27aac92775f03bc42fc889a54ba526e9
https://doi.org/10.1080/10550887.2022.2036575
https://doi.org/10.1080/10550887.2022.2036575
Infectious diseases of plants present an ongoing and increasing threat to international biosecurity, with wide-ranging implications. An important challenge in plant disease management is achieving early detection of invading pathogens in new location
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9422a567b117ad26c6b1a39585acad6
https://doi.org/10.1101/2022.09.01.506171
https://doi.org/10.1101/2022.09.01.506171
Although new cases of monkeypox have been expected in the Western Pacific Region (WPR) since the virus emerged in Europe earlier this year, there have been only a few reported cases across the WPR (New Zealand 2, Singapore 6, South Korea 1, Taiwan 2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcf8bbf55b37caa070e5968f9730feaa
http://wrap.warwick.ac.uk/167460/7/WRAP-emergence-potential-monkeypox-Western-Pacific-Region-Thompson-2022.pdf
http://wrap.warwick.ac.uk/167460/7/WRAP-emergence-potential-monkeypox-Western-Pacific-Region-Thompson-2022.pdf
Autor:
Fiona Forrestal, Howard Fillit, Peter Pemberton-Ross, William Herring, Ian Gopal Gould, Peter Lindgren, Robin Thompson
Publikováno v:
Neurology and Therapy
Introduction Alzheimer’s disease (AD) is a chronic and progressive neurodegenerative disease that places a substantial burden on patients and caregivers. Aducanumab is the first AD therapy approved by the US Food and Drug Administration to reduce a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62bcc4594f26792b08557bcbcb906b79
https://doi.org/10.1007/s40120-021-00273-0
https://doi.org/10.1007/s40120-021-00273-0
Autor:
Divita Kulshrestha, Nick H.M. van Bakel, Erik Storkebaum, Céline Sijlmans, Marica Catinozzi, Abigail L. D. Tadenev, Marije Been, Zoya Ignatova, Sarada Das, Robert W. Burgess, Amila Zuko, Moushami Mallik, Emily Spaulding, Robin Thompson, Anne R. Wienand, Leonardo A. Santos, Julia Bussmann
Publikováno v:
Science, 373, 1161-1165
Science, 373, 6559, pp. 1161-1165
Science, 373, 6559, pp. 1161-1165
Defeating peripheral neuropathy The mechanisms underlying peripheral neuropathies are not well understood. Spaulding et al . studied mouse models of the inherited Charcot-Marie-Tooth (CMT) disease, which is caused by mutations in transfer RNA (tRNA)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9df92c7a8ee63dc440dec34b5c9de451
https://hdl.handle.net/2066/237400
https://hdl.handle.net/2066/237400